Timing note: KO is scheduled to report before the U.S. market opens on Tuesday, July 28, 2026—today, rather than tomorrow, based on the date provided.
Coca-Cola enters the report with strong momentum and correspondingly high expectations. First-quarter results exceeded expectations, management raised full-year EPS guidance, and the shares closed July 27 at approximately $84.09, up about 20% since year-end 2025.
That leaves less room for a merely “in-line” quarter. Investors will probably care more about the quality of organic growth, second-half guidance, and the impact of Fairlife’s recent cyber disruption than about a small Q2 EPS beat.
| Metric | Q2 2026 consensus | Q2 2025 comparison |
|---|---|---|
| Adjusted EPS | ~$0.93 | $0.87 |
| Revenue | ~$13.2 billion | $12.54 billion reported |
| Organic revenue growth | ~3.5% | 5% |
| Unit case volume | Not uniformly disclosed | -1% |
The EPS estimate implies approximately 7% growth, broadly consistent with management’s full-year currency-neutral earnings algorithm. Reported revenue should benefit from foreign exchange, while divestitures—particularly the planned exit from Coca-Cola Beverages Africa—complicate the headline comparison.
Coca-Cola began 2026 with:
However, Q1 contained two meaningful timing benefits: six additional reporting days and concentrate shipments running ahead of consumer-level volumes. Management explicitly warned that Q2 concentrate shipments would lag unit cases by a couple of percentage points.
Accordingly, a sharp deceleration from Q1’s 10% organic growth is expected and should not automatically be interpreted as weaker consumer demand. The more useful test is whether KO can sustain its targeted balanced growth algorithm, with roughly low-single-digit contributions from both volume and price/mix.
A healthy result would likely contain:
Fairlife temporarily suspended U.S. production following a July cyber incident. Coca-Cola subsequently said the majority of production had resumed at Fairlife’s four U.S. facilities.
Because the disruption occurred after the likely end of the Q2 reporting period, the quarter’s reported results should see little direct impact. The important questions are prospective:
Fairlife was already capacity constrained in Q1, even before the cyber incident. Management had expected the Webster facility to begin ramping in Q2, making Fairlife an important part of the North American growth outlook. Any reduction to full-year guidance attributable to this event would likely overshadow a Q2 beat.
North America was a major Q1 strength:
But North American price/mix was only 1%, reflecting Easter timing, unfavorable category mix, and constraints at Fairlife and Topo Chico.
Investors should look for evidence that the region maintained positive volume as comparisons became more difficult. World Cup activations, Coca-Cola Zero Sugar, Diet Coke, mini cans, sports drinks, and stronger availability could support the quarter. Conversely, pressure on lower-income consumers and a shift toward value-oriented packages could weigh on mix.
The June announcement that North America President Jennifer Mann will leave the role effective August 1 also deserves attention. CFO John Murphy will oversee the operating unit on an interim basis. The change is unlikely to affect Q2 results, but investors may ask about the succession process and whether Murphy’s additional duties create execution risk.
Management has deliberately emphasized affordable packages and attractive absolute price points, especially for financially pressured consumers. That strategy supports penetration and volume but can produce unfavorable mix.
This was most visible in Asia Pacific, where Q1 unit case volume rose 5%, but price/mix fell 6%. China and India both posted solid volume growth, yet the region’s operating margin declined sharply because of unfavorable mix, tea and coffee inflation, higher marketing, and an inventory-cost timing item.
For Q2, the ideal outcome is continued Asian volume growth accompanied by a meaningful recovery in profitability. Investors should distinguish between:
If Asia Pacific margins remain weak despite the expected reversal of timing effects, questions about the return on those investments will intensify.
Management said approximately four points of Q1 pricing were offset by two points of unfavorable mix. It expects the full-year contribution from volume and price/mix to be more balanced.
Gross-margin commentary will be important because:
Coca-Cola itself has less packaging exposure than many bottlers, but system economics matter. Aggressive bottler pricing could eventually hurt affordability and volume, while inadequate pricing could pressure bottler investment and execution.
EMEA: Q1 volume grew despite a decline in Middle East demand after conflict escalated in March. Investors should expect an update on demand, supply continuity, and input inflation in the region.
Latin America: Brazil and Central America offset weakness in Mexico and Argentina during Q1. Mexico remains important following a sugar-tax increase, while geographic mix can materially affect reported price/mix.
Asia Pacific: China and India volume momentum is encouraging, but profitability needs to improve.
North America: This remains the largest operating unit and the main source of near-term Fairlife uncertainty.
Q1 comparable operating margin expanded approximately 70 basis points despite modest gross-margin pressure, helped by operating-expense efficiencies. Management said the Q1 Asia inventory issue should not recur and maintained a constructive full-year margin outlook.
For Q2, investors should examine:
A headline EPS beat driven primarily by taxes, securities gains, or other nonoperating income would be less convincing than one produced by organic revenue growth and operating-margin expansion.
Current 2026 guidance calls for:
At the July 27 closing price, KO trades at roughly 26 times the midpoint of current 2026 EPS guidance. That valuation suggests the market is already discounting dependable execution and some possibility of another guidance increase.
The best outcome would be:
A guidance cut—even if limited to the Fairlife incident—would probably receive more attention than an otherwise solid Q2.
Management expects the sale to close in the second half, subject to regulatory approval. Removing this lower-margin bottling operation should mechanically improve Coca-Cola’s consolidated margin profile, but it will reduce reported revenue and earnings. Any change in timing would affect the shape of second-half results.
Coca-Cola recorded a $960 million BodyArmor trademark impairment in late 2025, leaving a carrying value of approximately $2.44 billion. Management has warned that another impairment could be required if revised forecasts are missed. Investors should listen for evidence that sports-drink performance is stabilizing, although a detailed update may not come unless trends have changed materially.
The company has already deposited $6 billion related to its transfer-pricing dispute. It estimates that an adverse application of the Tax Court methodology to 2010–2025 could create roughly $14 billion of additional tax and interest exposure, before further accruals. This is unlikely to drive the Q2 operating reaction, but it remains KO’s largest balance-sheet tail risk.
This would support the view that KO can compound earnings at a high-single-digit rate despite macroeconomic and geopolitical volatility.
Given the stock’s strong run, an in-line report with unchanged guidance may produce a muted reaction.
The principal valuation risk is not one weak quarter by itself, but evidence that KO’s balanced volume-and-pricing model is becoming harder to sustain.
The Q2 numbers face expected noise from concentrate-shipment timing, divestitures, and currency. The most important indicators are therefore consumer-level volume, price/mix balance, and underlying margin performance.
The newest and most consequential variable is Fairlife. Since the cyber incident occurred after quarter-end, Q2 could still look strong while the second-half outlook deteriorates. Investors should focus closely on management’s assessment of lost production, customer inventories, recovery timing, and the impact on 2026 guidance.
With KO up roughly 20% year to date and trading near 26 times expected 2026 earnings, the market is likely to demand more than an EPS beat: it will want reassurance that the company’s growth algorithm—and especially its North American growth engine—remains intact.